不含麩質 - 本產品不含可檢測出之麩質*

不含可檢測出之基改成份(GMO) - 本產品不含可檢測出之基因改造生物成份

純素 - 本產品不含動物相關成份

等滲壓營養補充沖飲 - 易於飲用的營養補充品 / 健康食品，透過等滲壓狀態達致更佳的營養吸收

品質標準 - 良好生產規範(GMP)運作與標準化成份

已檢測：重金屬丶微生物污染物丶過敏原丶效力丶純度及特性

*美國食品藥品監督管理局（FDA）將含有少於20PPM麩質的製成產品列為不含麩質

葡萄籽萃取物 
葡萄籽萃取物主要提取自紅葡萄（非白葡萄）的籽，含有大量稱為原花色素(OPC)的複合物。這些原花色素亦存在於多種水果及蔬菜，包括松樹皮（內含的原花色素即為碧容健®）及綠茶，如葡萄籽萃取物一樣，它們均具抗氧化能力。這些抗氧化物有助保護細胞免受自由基損害，並促進心血管健康及正常視力。葡萄籽萃取物還擁有極豐富的多酚類，多酚類含有大量抗氧化物

紅酒萃取物
紅酒是天然存在的抗氧化物，存在於葡萄藤、根、籽及莖，於葡萄皮的含量更是最高。紅酒的抗氧化特質比白酒強很多，這帶來一個惹人爭論的概念。90年代末，科學家留意到關於法國人的一個現象：某些省份的人進食較高脂肪的食物並同時飲用紅酒，而從古至今這些人心臟健康的比率非常高。紅酒的特性相信可保護心臟健康。此外，試管及動物身上測試顯示，紅酒萃取物有助令血管保持張開及有彈性。

松樹皮萃取物（碧容健，Pycnogenol®）
碧容健®（Pycnogenol®）是由海岸松樹皮提取的天然植物萃取物；海岸松樹只生長在法國西南部沿岸的加斯科尼地區。這不受污染的天然樹林就是碧容健®的唯一來源。碧容健®擁有三項基本特質：抗氧化、選擇性結合膠原蛋白及彈力蛋白，以及協助內皮細胞製造一氧化氮；一氧化氮能促進血液的正常舒張。

碧容健®作為最強效的天然自由基對抗物，能去除所有具侵略性的自由基，阻止自由基透過氧化壓力損害人體。碧容健的抗氧化能力有助鞏固血管壁及毛細血管，更有助維持正常的血液循環及細胞活力。

現時，碧容健®是天然產品巿場上受到最廣泛研究的成份之一。

歐洲藍莓萃取物
歐洲藍莓萃取物提取自歐洲一種普遍矮灌木的果實，這種植物與藍莓非常近似。

成熟的莓類萃取物含有稱為花青素的黃酮類色素，它們具有抗氧化功效。科學研究顯示，歐洲藍莓有助支援視力及靜脈健康。歐洲藍莓萃取物亦可鞏固毛細血管及動脈。

柑橘生物類黃酮複合物        
生物類黃酮是存在於部份植物的物質，是吸收紫外線輻射的光線過濾器，保護植物裡容易受損的DNA鏈及其他重要的大分子。

甚麼是Isotonix OPC-3沖飲？
Isotonix OPC-3 沖飲是一種等滲壓營養補充品，由葡萄籽、紅酒和松樹皮萃取物組合而製成。等滲壓營養補充品的化學性質與人體眼淚及血漿相似，讓人體能迅速並有效地吸收內含的營養。

甚麼是生物類黃酮？
生物類黃酮是存在於植物的有機植物複合物。這些複合物雖然在化學上互有關連，但不同植物的生物類黃酮的化學性質都不一樣。最顯而易見的例子是，不同水果與植物顏色不同，是因為它們含有不同種類的生物類黃酮。越來越多臨床研究顯示，生物類黃酮可促進人體健康和血管完整性。

Isotonix OPC-3沖飲與其他生物類黃酮產品有何不同？
Isotonix OPC-3沖飲提供的原花色素獲科學證實可支援健康，結合Isotonix等滲壓傳輸系統，讓人體能有效並迅速地吸收產品提供的營養。

可以汽水、果汁或咖啡等飲品代替水混合Isotonix OPC-3沖飲飲用嗎？
可以，但我們並不建議。為了保持產品的等滲壓狀態，並達到最高傳送速度，每瓶蓋Isotonix OPC-3沖飲需以60毫升的水空肚飲用。如果以其他飲品混和飲用，會減慢傳送速度，並可能影響吸收率。

Isotonix OPC-3沖飲有明顯可見的好處嗎？
關注自己的健康固然重要，但我們最終亦希望別人留意到我們的狀態很好！

由於原花色素能促進皮膚的膠原蛋白製造，皮膚的柔滑度與彈性自然會提升。事實上，這效果是從40歲或以上女士身上客觀量度出來的。肌膚細胞需要時間修復大量膠原蛋白，因此人們必須有耐性等待效果顯現。為了使肌膚細胞時刻保持最佳活力，我們建議必須持續飲用OPC-3沖飲。

短期效果方面，很多人都發現飲用OPC-3沖飲後，肌膚明顯變得更亮麗。這是血液微循環健康的結果，這有助肌膚排毒及改善營養供應。

飲用Isotonix OPC-3沖飲安全嗎？
Isotonix OPC-3沖飲安全及不含有害物質。本產品在美國製造，並於經美國食品及藥物管理局檢測的設備生產，符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

• Araghi-Niknam M, et al.. Pine bark extract reduces platelet aggregation. Integr. Med. 2000 Mar 21;2(2):73-77
• Bayeta, E., et al. Pycnogenol inhibits generation of inflammatory mediators in macrophages. Nutrition Research 20: 249-259, 2000.
• Bertelli AA, et al. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res 1996;22:61–3.
• Blazsó, G., et al. Anti-inflammatory and superoxide radical scavenging activities of a procyanidins containing extract from the bark of Pinus pinaster Sol. and its fractions. Pharm Pharmacol Lett 3: 217-20, 1994.
• Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 1996;27:363–6.
• Cho, K., et al. Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interlukin-1 production in lipopolysaccharide-stimulated RAW 264. 7. Toxicology and Applied Pharmacology 168: 64-71, 2000.
• Cho, K., et al. Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines. Annals of the NY Academy of Sciences 928: 141-156, 2001.
• Devaraj, S., et al. Supplementation with a pine barks extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids 37:931-4, 2002.
• Fine, A. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern Med Rev 5:144-51, 2000. Review.
• Fitzpatrick, D., et al. Endothelium-dependent vascular effects of Pycnogenol. Journal of Cardiovascular Pharmacology 32: 509-515, 1998.
• Frankel, E., et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-7, 1993.
• Freedman, J., et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103:2792-8, 2001.
• Frémont, L. Biological effects of resveratrol. Life Sciences 66: 663-673, 2000.
• Gulati, O. Pycnogenol^® in venous disorders: a review. European Bulletin of Drug Research 7: 1-13, 1999.
• Hosseini, S., et al. Pycnogenol^® in the management of asthma. Journal of Medicinal Food 4: 201-209, 2001. HHHh
• Huynh HT, Teel RW. Effects of pycnogenol on the microsomal metabolism of the tobacco-specific nitrosamine NNK as a function of age. Cancer Lett. 1998; 132:135-139.
• Jang M, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218–20.
• Kohama, T., et al. Analgesic efficacy of French maritime pine bark extract in dysmenorrhea. Journal of Reproductive Medicine 49: 828-32, 2004.
• Kohama, T., et al. The treatment of gynecological disorders with Pycnogenol^®. European Bulletin of Drug Research 7: 30-32, 1999.
• Liu, X., et al. Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci 75:2505-13, 2004.
• Liu, X., et al. French maritime pine bark extract pycnogenol dose-dependently lowers glucose in type 2 diabetic patients. Diabetes Care 27: 839, 2004.
• Manna, S., et al. Resveratrol suppresses TNF-Induced activation of nuclear transcription factors NF-kB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. The Journal of Immunology 164: 6509-19, 2000.
• Maritim, A., et al. Effects of pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 17:193-9, 2003.
• Miyagi, Y., et al. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 0:1627-31, 1997.
• Miztuani K, et al. Extract of wine phenolics improves aortic biomechanical properties in stroke-prone spontaneously hypertensive rats (SHRSP). J Nutr Sci Vitaminol (Tokyo). 1999 Jan;45 (1):95-106.
• Monograph. Vaccinium myrtillus (bilberry). Altern Med Rev 6:500-4, 2001.
• Murias, M., et al. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12: 5571-8, 2004.
• Nuttall SL, et al. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther 23: 385-89, 1998.
• Pace-Asciak CR, et al. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996;246:163–82.
• Packer, L., et al. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med 27:704-24, 1999. Review.
• Petri G, et al. Spectrophotometric and chromatographic investigation of bilberry anthocyanins for qualification purposes. Acta Pharm Hung. 1994 Jul;64(4):117-22.
• Rohdewald, P. A review of the French maritime pine bark extract (Pycnogenol^®), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40:158-68, 2002. Review.
• Rohdewald, P. Pycnogenol^®. In “Flavonoids in Health and Disease”. Ed. Catherine Rice-Evans and Lester Packer. New York: Marcel Dekker, Inc., 1998. 405-19.
• Roseff, S., et al. Improvement in sperm quality and function with French maritime pine tree bark extract. Journal Reproductive Medicine 47: 821-4, 2002.
• Saito, M., et al. Antiulcer activity of grape seed extract and procyanidins. J Agric Food Chem 46: 1460-4, 1998.
• Sato M, et al. Cardioprotective effects of grape seed proanthocyanidins against ischemic reperfusion injury. J Mol Cell Cardiol. 1999; 31:1289-1297 
• Schönlau, F., et al. Pycnogenol^® for diabetic retinopathy. International Ophthalmology 24: 161-171, 2002.
• Schönlau, F., et al. The cosmeceutical Pycnogenol^®. J Appl Cosmetology 20: 241-6, 2002.
• Segger, D. and Schönlau, F. Supplementation with Evelle^® improves skin smoothness and elasticity in a double-blind, placebo-controlled study with 62 women. Journal of Dermatological Treatment 15:222-26, 2004.
• Sharma, S., et al. Pycnogenol^® inhibits the release of histamine from mast cells. Phytotherapy Research 17: 66-69, 2003.
• Shi, J., et al. Polyphenolics in grape seeds-biochemistry and functionality. J Med Food 6:291-9, 2003. Review.
• Spadea, L., et al. Treatment of vascular retinopathies with Pycnogenol^®. Phytotherapy Research 15: 219-23, 2001.
• Stein, J., et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050-5, 1999.
• Takada, Y., et al. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 23: 9247-58, 2004.
• Ueda, T., et al. Preventative effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eye. Ophthalmic Res 28: 184-92, 1996.
• Wallerath, T., et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652-8, 2002.
• Watson, R. Pycnogenol^® and cardiovascular health. Evidence-Based Integrative Medicine 1: 27-32, 2003.
• Wei, Z., et al. Pycnogenol enhances endothelial cell antioxidant defense. Redox Report 3: 219-24, 1997.
• Yamakoshi, J., et al. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 142:139-149, 1999.